These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4144466)

  • 1. Inhibition of allograft reactivity in vitro and in vivo, by Fab fragments obtained from ALG.
    Gallagher MT; Richie ER; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):869-72. PubMed ID: 4144466
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the graft-versus-host reaction. III. Altered in vivo distribution of spleen cells pretreated with Fab fragments of antithymocyte globulin.
    Richie ER; Monié HJ; Trentin JJ; Taub RN
    Transplantation; 1975 Feb; 19(2):115-20. PubMed ID: 235162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological effects of heterologous antilymphocyte serum.
    Taub TN
    Prog Allergy; 1970; 14():208-58. PubMed ID: 4404047
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts.
    Maki T; Gottschalk R; Homsy FN; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):596-8. PubMed ID: 6455803
    [No Abstract]   [Full Text] [Related]  

  • 9. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 10. Diversity of T cells recognizing transplantation antigens: mechanism of antigen recognition.
    Wekerle H; Lanai P; Feldman M
    Transplant Proc; 1973 Mar; 5(1):133-6. PubMed ID: 4144457
    [No Abstract]   [Full Text] [Related]  

  • 11. Physical properties of mouse spleen cells involved in the mixed leukocyte reaction and graft-vs-host disease.
    el-Arini MO; Osoba D
    J Immunol; 1973 Jun; 110(6):1476-84. PubMed ID: 4145892
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the mixed lymphocyte reaction with fab fragments from anti-human ALG.
    Richie ER; Gallagher MT; Heim LR; South MA; Trentin JJ
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):916-9. PubMed ID: 5039391
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI).
    King DP; Srober S; Kaplan HS
    J Immunol; 1981 Mar; 126(3):1140-5. PubMed ID: 6450802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of T and B lymphocytes and their role in the mixed lymphocyte reaction.
    von Boechmer H
    J Immunol; 1974 Jan; 112(1):70-8. PubMed ID: 4272924
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of natural thymocytotoxic autoantibody of NZB mice and of specifically prepared antilymphocyte serum on the tissue distribution of 51 Cr-labeled lymphocytes.
    Shirai T; Yoshiki T; Mellors RC
    J Immunol; 1973 Feb; 110(2):517-23. PubMed ID: 4539675
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of antilymphocyte globulin for leukemia induction in mice.
    Radzikowski C; Szkudlarek J; Czarnomska A; Steuden J; Krajewski L
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):697-711. PubMed ID: 793567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of HL-A antibodies on lymphocyte transformation in vitro.
    Thorsby E; Bondevik H; Solheim BG
    Transplant Proc; 1973 Mar; 5(1):343-8. PubMed ID: 4266658
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in thymus and spleen cell populations and immune reactivity during syngeneic pregnancy and lactation.
    Gambel PI; Cleland AW; Ferguson FG
    J Clin Lab Immunol; 1980 Mar; 3(2):115-9. PubMed ID: 6451708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus origin of lymphocytes reacting and stimulating reaction in mixed lymphocyte cultures--studies in the rat.
    Maclaurin BP
    Clin Exp Immunol; 1972 Apr; 10(4):649-59. PubMed ID: 5034246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.